For cardiovascular health specifically, Canadians have well-established conventional options through the healthcare system
We observed that GLP-1RAs were associated with reduced levels of BMI (OR 0.70 [95% CI 0.490.99], P = 4.50 10 2 ), current tobacco smoking (OR 0.77 [95%CI 0.670.89], P = 2.98 10 4 ), and alcohol consumption (OR 0.72 [95% CI 0.550.95], P = 2.07 10 2 )
Additionally, insulin manufacturers have set monthly copays at $35 for eligible patients
Tirzepatide for Weight Loss: Are You a Candidate
For a holisitc view of the treatment landscape for MASH, our clinical insights white paper, Metabolic dysfunction-associated steatohepatitis (MASH) A new era in liver health, provides a comprehensive look at emerging approaches to liver care
What the Research Shows on Weight Loss Clinical trials of bupropion-naltrexone (Contrave) have shown average weight loss of around 5 percent of body weight over one year in patients who also follow a reduced-calorie diet and exercise program
